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China
Schistosomes are metazoan parasites and can cause schistosomiasis. Epigenetic
modifications include DNA methylation, histone modifications and non-coding RNAs.
Some enzymes involved in epigenetic modification and microRNA processes have been
developed as drugs to treat the disease. Compared with humans and vertebrates,
an in-depth understanding of epigenetic modifications in schistosomes is starting
to be realized. DNA methylation, histone modifications and non-coding RNAs play
important roles in the development and reproduction of schistosomes and in interactions
between the host and schistosomes. Therefore, exploring and investigating the
epigenetic modifications in schistosomes will facilitate drug development and therapy for
schistosomiasis. Here, we review the role of epigenetic modifications in the development,
growth and reproduction of schistosomes, and the interactions between the host and
schistosome. We further discuss potential epigenetic targets for drug discovery for the
treatment of schistosomiasis.
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INTRODUCTION
Schistosomiasis is a parasitic disease that is caused by schistosomes. More than 200 million people
are infected with schistosomes worldwide. However, only one drug, praziquantel, is available for the
treatment of this condition, and drug resistance to praziquantel is an important concern (Bergquist
et al., 2008). Therefore, the identification of new drug targets is urgently needed. Schistosomes are
digenean parasites, which can infect intermediate hosts (snails) and definitive hosts (vertebrates).
Schistosomes can live in the body of the definitive host for several decades, suggesting that
expression and regulation of genes could affect their development and reproduction. Epigenetics
is an important feature of gene regulation and expression. Some enzymes that are involved in
epigenetic modifications have been developed as drug targets against human disease, including
two histone deacetylase (HDAC) inhibitors (Arrowsmith et al., 2012). Therefore, a detailed
understanding of the epigenetics of schistosomes and an exploration of the possible underlying
mechanisms will provide useful information for understanding the epigenetics of schistosomes and
the development of drugs against schistosomiasis.
In a broad sense, epigenetics generally refers to changes in gene expression that are stable
between cell divisions, and sometimes between generations, but these changes do not involve
alterations in the underlying DNA sequence of the organism (Jiang et al., 2004; Portela and Esteller,
2010). The carriers of epigenetic information are DNA methylation, histone modifications, and
non-coding RNAs, the relocation of a nucleus to a nuclear compartment and modifications of this
information might affect different processes, including genome stability. Here, we will discuss the
mechanisms underlying DNA methylation and the modification of histones and microRNAs, and
their potential roles in schistosomes and in therapies designed to treat schistosomiasis (Figure 1).
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FIGURE 1 | The effects of epigenetic modifications on the interaction
between schistosomes and hosts, drug targets against
schistosomiasis, and biomarkers for the diagnosis of schistosomiasis.
DNA methylation, histone modifications, and miRNAs play important roles in
epigenetic modifications in the interaction between schistosomes and hosts.
DNA methyltransferases, histone acetyltransferases (HATs), and histone
deacetylase are potential drug targets against schistosomiasis. In addition, the
levels of DNA methylation and miRNAs can be used as diagnostic biomarkers
for schistosomiasis.
MECHANISMS
DNA Methylation
DNA methylation requires the participation of
DNA methyltransferases. In this process, three DNA
methyltransferases (Dnmts) establish (Dnmt3a and Dnmt3b)
and maintain (Dnmt1) DNA methylation (Hamidi et al., 2015).
DNMT1 is considered to maintain the methyltransferase
that is responsible for copying DNA methylation patterns to
the daughter strands during DNA replication; DNMT3a and
DNMT3b are considered to be the de novo methyltransferases
that construct DNA methylation patterns and are essential
for mammalian development; Dnmt2 is primarily a tRNA
methyltransferase with only weak DNA methyltransferase
activity (Liyanage et al., 2014; Meng et al., 2015). In vertebrates,
∼70–80% of cytosines in CpG islands are methylated (Jabbari
and Bernardi, 2004). As a general rule, methylated cytosines
recruit methylated CpG-binding proteins (MBDs) to alter
the chromatin structure and silence gene expression (Lo and
Weksberg, 2014). In contrast, most invertebrates display a wide
range of DNA methylation in the form of a mosaic pattern
(Suzuki et al., 2007; Suzuki and Bird, 2008). In invertebrates,
DNA methylation may not be limited to the canonical CpG
targets but is also present as a mosaic pattern, referring to tracts
of methylated CpGs that are interspersed with unmethylated
regions across the genome (Figure 2A). Moreover, methylated
genes can be actively transcribed via alternative splicing in
several invertebrates (Flores et al., 2012).
In addition to the methylation or hydroxymethylation of
cytosine residues, DNA methylation in lower eukaryotes also
involves the modification of adenine to N6-methyladenine
(m6A) (Tchurikov, 2005; Ratel et al., 2006), such as Trypanosoma
brucei TbPRMT6, which, like human PRMT6, catalyzes
the production of monomethylarginine and asymmetric
dimethylarginine residues (Lott et al., 2014; Wang et al., 2014).
Modification of Histones
The modification of histones often takes place at the tails of
the histone (Imhof, 2006; Lennartsson and Ekwall, 2009).
The varieties of possible histone modifications include
phosphorylation, ubiquitinylation, sumoylation, acetylation
and methylation (Berger, 2002; Peterson and Laniel, 2004).
Histone acetylation is processed by histone acetyltransferases
(HATs) and transfers an acetyl residue to lysines, particularly
in the N-terminal tails of histones H3 and H4 (Peterson and
Laniel, 2004). Acetyl-CoA is used as a co-factor in this process. In
contrast, HDAC removes the acetylation of histone. In humans,
18 HDACs have been identified and classified according to
their co-factor dependency on either zinc or NAD+ and their
sequence homology to yeast proteins (Marks and Xu, 2009).
Classes I, II, and IV have structurally related catalytic domains
and a Zn2+-dependent catalytic mechanism (Gregoretti et al.,
2004). The class III HDACs, or sirtuins, are phylogenetically
unrelated and rely on NAD+ as a co-factor (Greiss and
Gartner, 2009). Histone acetylation can result in a more relaxed
structure of chromatin, and the transcriptional machinery is
permitted to recruit and consequently activate transcription
(Figure 2B).
Histone methylation is completed by S-adenosylmethionine-
dependent methyltransferase and occurs on lysine or arginine
residues in histone tails (Beaver and Waters, 2016). Histone
methylation has been shown to play a role in both transcriptional
activation and repression (Wang et al., 2001; Jeong et al.,
2011; Kallestad et al., 2014; Figure 2B). Histone demethylation
is mediated by two classes of demethylase: the Jumonji
family and the flavin-dependent lysine-specific demethylase1
(KDM1/LSD1) and 2 (KDM2/LSD2) (Pedersen and Helin, 2010).
Histone phosphorylation is a dynamic modification in
which a phosphate group is added to a specific amino
acid residue such as serine, threonine or tyrosine. Histone
phosphorylation is implicated in multiple cellular processes.
For example, phosphorylation of histone H1, H3, H2AX, and
H2B is involved in the regulation of transcription, mitotic
chromatin condensation, DNA damage responses and apoptosis,
respectively (Hans and Dimitrov, 2001; Celeste et al., 2003;
Cheung et al., 2003; Nowak and Corces, 2004; Bungard et al.,
2010; Sharma et al., 2012).
Non-coding RNAs
Non-coding RNAs are classes of functional RNAs that do
not encode protein but have important roles in translation,
gene regulation, and RNA splicing, among others (Santosh
et al., 2015). Non-coding RNA genes include highly abundant
and functionally important RNAs, such as tRNA, rRNA,
snoRNA, microRNA, siRNA, piRNA, and lncRNA. Among these,
microRNAs are the best characterized. A microRNA (miRNA) is
a small non-coding RNA molecule consisting of approximately
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FIGURE 2 | Mechanisms of DNA methylation, histone modifications and miRNAs. (A) DNA methylation landscapes in invertebrates. Mosaic methylation is
characteristic of most invertebrates. Mosaic methylation comprises domains of heavily methylated DNA interspersed with domains that are free of methylation. Mosaic
DNA methylation consists of stable methylated (yellow) and unmethylated (blue) domains. The stable methylated and unmethylated domains are interspersed.
Transposable elements are frequently unmethylated and match the methylation status of the surrounding DNA (red box). (B) Methylation and acetylation of histones.
Histone acetylation can neutralize the positive charge of lysine, leading to a more relaxed structure of chromatin. The transcriptional machinery recruitment is
permitted, and consequently transcription is activated. Histone methylation has been shown to be present during both transcriptional activation and repression.
(C) The generation of miRNAs. The microRNAs are generated from long, capped, hairpin and polyadenylated pre-miRNAs, which are usually transcribed by RNA
polymerase II (Pol II). Pre-miRNAs are processed by Drosha or Exportin-5, and then they are transported into the cytoplasm to be processed by RNase Dicer into
mature double-stranded miRNAs.
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21–25 nucleotides that functions in a wide range of pivotal
biological processes such as development, cell proliferation and
differentiation, cell death, metabolism, and signal transduction
(Carrington and Ambros, 2003; Hwang and Mendell, 2006;
Fendler et al., 2011; Sayed and Abdellatif, 2011). MicroRNAs
are generated from long, capped, hairpin and polyadenylated
pre-miRNAs, which are usually transcribed by RNA polymerase
II (Pol II). Pre-miRNAs are processed by Drosha or Exportin-
5 and then transported into the cytoplasm where they are
processed by the RNase Dicer into mature, double-stranded
miRNAs (Figure 2C). MiRNAs usually regulate transcript levels
by binding to the 3′UTR of their target mRNAs, resulting in
mRNA degradation or translational inhibition.
MiRNAs play important roles in the regulation of gene
expression, but a subgroup of these ncRNAs (defined as epi-
miRNAs) directly and indirectly control the expression of
epigenetic effectors such as DNMTs and HDACs, shedding new
light on the functions of miRNAs as both genetic and epigenetic
regulators (Valeri et al., 2009; Fabbri and Calin, 2010; Sato et al.,
2011). Based on the term epi-miRNAs, these miRNAs directly
or indirectly target effectors of the epigenetic machinery. For
example, HDAC4 has been confirmed to be one of the important
targets of miR-140 (Song et al., 2009), whereas miR-449a binds to
the 3′UTR of HDAC1 (Noonan et al., 2009; Liu et al., 2015).
EPIGENETIC STUDIES IN
SCHISTOSOMES: WHAT IS KNOWN?
DNA Methylation
Previously, the genome of Schistosoma mansoni was considered
to lack detectable DNA methylation patterns (Raddatz
et al., 2013). Recently, cytosine methylation was found to
be a conserved epigenetic feature throughout the phylum
Platyhelminthes, including Schistosoma haematobium,
Schistosoma japonicum, and S. mansoni (Geyer et al.,
2013). In addition to cytosine methylation, the arginine
methyltransferase PRMT1 homolog was identified in S. mansoni
and S. japonicum (Mansure et al., 2005; Diao et al., 2014).
Dnmt2 and methyl-CpG-binding domain proteins (MBD) are
present in the S. mansoni genome, and methylation deficiencies
of the schistosome genome in this epigenetic process affect
oviposition and ovarian morphology in adult worm pairs treated
with the DNA methyltransferase inhibitor 5-AzaC (Geyer
et al., 2011). These findings further demonstrate that DNA
methylation machinery exists in different lifecycle stages, that
methylation occurs in a highly repetitive intronic region and
that targeting cytosine methylation components with selective
demethylating agents provides a promising new avenue to
combat schistosomiasis.
DNA methylation of the host was modified after schistosome
infection. For example, CpG island methylation in schistosoma-
associated bladder cancer displays a higher methylation index
compared with that in non-schistosoma-associated bladder
cancer(Gutierrez et al., 2004); during S. mansoni infection, a
population of IFN-γ/IL-4 double-positive cells was found to
display a discrete DNA methylation pattern in CpG islands
within the body of the Gata3 gene, which encodes the master
regulator of Th2 identity. Furthermore, expression of the Gata3
gene in IFN-γ (+) IL-4(+) cells was lower than that in IFN-γ
(+) IL-4(−) (Th1) and IFN-γ (−) IL-4(+) (Th2) cells (Deaton
et al., 2014). The DNA methylation state can be used as a
biomarker for schistosome infection. In S. haematobium, the
promoter of RASSF1A and TIMP3 is hypermethylated and can
serve as a biomarker of S. haematobium infection (Zhong et al.,
2013).
Modification of Histones
To date, only a few studies have been conducted to investigate
histone marks and their roles in schistosome development
and reproduction. However, histone modifications have been
identified in different life stages of schistosomes, and changes
in histone modifications appear to be crucial for pathogenesis
and thus to represent therapeutic targets. For example, bivalent
histone H3methylation was observed in cercariae, demethylation
of H3K27 and activation of transcription were observed during
the transformation into schistosomula (remaining absent in
adults), and alterations of H3K9 methylation and acetylation
occurred upstream and downstream of the transcriptional start
site (TSS) (Roquis et al., 2015). In schistosomes, sex is genetically
determined by the presence of sex chromosomes: ZZ in males or
ZW in females and the phenotypic sexual dimorphism appears
only after infection of the vertebrate definitive host. Picard
et al. compared H3K27me3 histone modification before (in
cercariae) and after (in adults) the phenotypic sexual dimorphism
appearance (Picard et al., 2016). The H3K27me3 enrichment
profile in cercariae differs between the two sexes both upstream
and along the transcription unit, whereas in the adult stage, males
and females display the same profile after the TSS, while their
profile upstream the TSS remains different (Picard et al., 2016).
These results suggest epigenetic regulators play important roles in
the sex determination and sexual differentiation in schistosomes
and represent a promising source of therapeutic targets. In the
adaption between the schistosome and its intermediate host,
histonemodifications also play important roles. Themodification
profiles of four histone modifications (H3K4me3, H3K27me3,
H3K27ac, and H4K20me1) were different between the sympatric
host and allopatric host and these histone marks also differ
in cercariae and adult (Roquis et al., 2016). The promoters of
the S. mansoni mucin gene (SmPoMuc), a key component of
the compatibility between the schistosome and its snail host,
contains the epigenetic marks H3K9Met3 and H3K9Ac, which
differ significantly between compatible (C) and incompatible
(IC) strains and negatively regulates the expression of SmPoMuc
(Fneich et al., 2016). The structure of the parasite chromatin
differentially modifies the transcription of SmPoMuc in the IC
strain compared with the C strain (Perrin et al., 2013). These
findings suggest that histone alterations may be important for
the initial steps in the adaptation of pathogens to new hosts
and epidrugs can be used to control parasite development.
The identification of HDACs and HAT in schistosomes has
also revealed the importance of HDACs and HAT as potential
therapeutic targets. Based on evidence for the expression of
all S. mansoni histones among the entire set of public ESTs,
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five histone families (H1, H2A, H2B, H3, and H4) were
detected during all six life cycle stages of the parasite (with
the exception of H4 in germ balls, the second least sequenced
stage) (Anderson et al., 2012). The HATs, GCN5, was identified
in S. mansoni, and specific acetylation at H3K14 was catalyzed
by the transcriptional co-activator GCN5 (de Moraes Maciel
et al., 2004, 2008). Sm CBP/p300 was also identified in S.
mansoni, and it was expressed during all life cycle stages,
interacted functionally with the nuclear receptor SmFtz-F1 and
also potentiated the transcriptional activity of this receptor
in the CV-1 cell line (Bertin et al., 2006). Knocking down
SmGCN5 or SmCBP1 significantly decreased the transcription
and protein synthesis of Smp14, an eggshell protein in the mature
female worm, damaging the reproductive system of mature
female worms, egg-laying and egg morphology (Carneiro et al.,
2014). This result suggests that inhibition of Smp14 expression
targeting SmGCN5 and/or SmCBP1 represents a novel and
effective strategy to control S. mansoni egg development and
that HATs can be used as a drug target against schistosomiasis.
Regarding HDAC, the NAD+-dependent HDAC, smSirt2 in S.
mansoniwas identified using fluorescence-based screening assays
(Schiedel et al., 2015). The class I HDAC s, SmHDAC1, 3,
and 8, were identified in S. mansoni (Oger et al., 2008; Marek
et al., 2013; Singh and Pandey, 2015). Additionally, inhibitors
of HDACs (HDACi) like TSA and valproic acid can induce
schistosome death (adult worms or schistosomula larvae) in
culture and increase caspase 3/7 activity (Dubois et al., 2009).
This finding provides preliminary information regarding the
potential of schistosome HDAC as a potential drug target for
schistosomiasis.
Schistosome miRNAs
Because miRNAs act as critical post-transcriptional regulators
in many organisms, studies have been conducted to determine
the roles of miRNAs in schistosomes. These miRNAs are
likely to play critical roles in schistosome development and
gene regulation. To date, a total of 79 mature miRNAs in S.
japonicum and 225 mature miRNAs in S. mansoni have been
characterized in miRBase. Five schistosome-specific miRNAs,
including four known miRNAs (Bantam, miR-3479, miR-10
and miR-3096) and one novel miRNA (miR-0001, miRBase ID:
sja-miR-8185), have been characterized as schistosome-specific
small RNA populations by Cheng et al. (Cheng et al., 2013).
Different miRNAs participate in the different developmental
stages of schistosomes. For example, in S. japonicum, sja-miR-
71b-5p, sja-miR-1, sja-miR-36-3p, and sja-miR-124-3p were the
most abundant miRNAs during the egg stage (Cai et al., 2013);
sja-bantam expression was highest in the cercaria stage (Xue
et al., 2008); and sja-miR-71 was highest during both the
cercaria stage and the egg stage (Xue et al., 2008; Cai et al.,
2011). In S. mansoni, 112 miRNAs (including 84 novel miRNA
families) have been reported in adult worms of S. mansoni
(Marco et al., 2013); miR-4, miR-6, miR-9, miR-32, miR-125,
miR-3, and miR-5 are expressed in adult worms only, and
miR-20, miR-18, miR-22, miR-26 and bantam are expressed in
schistosomula only (Simões et al., 2011). Thirteen microRNAs
exhibit sex-biased expression, 10 of which are more abundant
in females than in males, such as mir-31, mir-8447, bantam
and mir-8437 (Marco et al., 2013). The miRNAs bantam and
miR-31 are associated with the morphological formation of
ovaries in female schistosomes in S. japonicum (Zhu et al.,
2016). These results demonstrate that during the life cycle of
schistosomes, different microRNAs are likely to participate in
differentiation/maintenance processes. The miRNAs have been
shown to be different in distinct hosts. Compared with permissive
BALB/c mice, rats are less susceptible to S. japonicum infection
and are considered to provide an unsuitable microenvironment
for parasite growth and development. Forty-one differentially
expressed miRNAs have been identified in comparisons of rats
and mice (Han et al., 2015). One hundred sixty-two miRNAs
are expressed in M. fortis in mice, with 12 in the liver, 32 in
the spleen and 34 in the lung being differentially expressed in
M. fortis (Han et al., 2013). These results indicate that some
differentially expressed miRNAs may impact the survival and
development of the parasite within different hosts. MiRNAs
also play roles in the host after schistosome infection. The
altered levels of miR-706 and miR-134-5p between uninfected
and infected mice are associated with altered expression levels of
the Caspase-3 and Creb1 genes, respectively (Zhu et al., 2015).
MiR-454, a target miRNA of Smad4, is down-regulated in the
S. japonicum-induced murine liver in models of fibrosis, while
the expression of Smad4 is up-regulated. These results suggest
that circulating miRNAs may serve as important mediators
of the pathology of hepatic schistosomiasis. Furthermore, the
miRNA profiles in different tissues (liver, spleen, and lung)
of S. japonicum-infected mice suggest that miRNAs may be
involved in the regulation of several signaling pathways—such
as the MAPK, insulin, Toll-like receptor, and TGF-β pathways—
during schistosome infection (Han et al., 2013). Inhibition
of microRNA-21 can protect mice against lethal schistosome
infection by repressing both the IL-13 and transforming growth
factor beta 1 (TGFβ1) pathways (Sombetzki et al., 2015).
These results suggest that some signaling pathways in the
host may be affected by schistosome infection. Circulating
miRNAs, which are present in a stable form in the plasma or
serum, have been considered to be ideal biomarkers for the
diagnosis of some cancers. It is possible that such circulating
miRNAs could also serve as biomarkers for the diagnosis of
schistosomiasis. Three of the parasite-derived miRNAs (miR-
277, miR-3479-3p and bantam) in host serum can be used as
novel biomarkers of S. mansoni infection (Hoy et al., 2014).
The expression levels of serummiR-223 are significantly elevated
after infection, but they return to nearly normal levels following
treatment with praziquantel (PZQ) (He et al., 2013), implying
that murine miR-223 may be a biomarker for schistosome
infection.
EPIGENETIC REGULATION IN
SCHISTOSOMES: WHAT KNOWLEDGE IS
NEEDED?
The availability of the genome sequence of schistosomes has been
a useful tool for the investigation of epigenetic modification in
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schistosomes. The epigenomic profile of schistosomes remains
poorly understood, although great advances have been achieved
in the epigenome of model organisms such as the human and
mammalian brain (Lister et al., 2013;Wen et al., 2014). Currently,
great advancements have been achieved in EPIGENOME and
ENCODE in humans to illustrate the epigenetics and DNA
elements in the human genome (Birney et al., 2007; Gerstein
et al., 2012; Schultz et al., 2015; Tang et al., 2015). In
comparison to the advancements in humans, the DNA elements
and transcription factors that are involved in gene expression
and regulation in schistosomes remain to be elucidated. The
schistosome life cycle is complex; however, the epigenetic profiles
of these developmental stages are not clear and may differ in
different hosts. Therefore, an exploration of the epigenetic profile
during different development stages and in different hosts is
needed. Epigenetic modifications can regulate gene expression,
yet the mechanism(s) by which epigenetic modifications in
schistosomes regulates gene expression in the host or the parasite
remains unclear. In addition, although the enzymes involved
in DNA methylation have been identified in schistosomes, the
mechanisms responsible for DNA demethylation in schistosomes
have not been determined. MiRNAs are best characterized
in terms of their functions and implications, but recently a
new class of non-coding RNA lncRNAs was identified in the
genome. Long non-coding RNAs (long ncRNAs, lncRNAs)
are non-protein-coding transcripts that are longer than 200
nucleotides (Mercer et al., 2009). The lncRNAs also have roles
in epigenetic regulation (Vadaie and Morris, 2013; Chen and
Xue, 2016). For example, one ncRNA, termed HOTAIR, which
is a HOX antisense intergenic RNA, interacts with key epigenetic
regulators such as histone methyltransferase PRC2 and histone
demethylase LSD1 and regulates gene silencing (Tsai et al., 2010).
Although lncRNA has been described in other organisms, its
role in schistosomes remains unknown. In addition, although
some microRNAs have been identified in schistosomes, epi-
miRNAs that control the expression of epigenetic effectors,
such as DNMTs and HDACs, have not been recognized in
schistosomes.
HAT and HDAC have been recognized in schistosomes;
however, the molecules involved in histone methylation,
histone phosphorylation and other histone modifications in
schistosomiasis remain undescribed. Furthermore, the histone
marks and their possible roles in schistosome development
and reproduction require further elucidation in future
studies.
Snails serve as the obligate intermediate host of this
parasite and might be manipulated to block the development
of intramolluscan larval stages of the parasite. Therefore,
the epigenome of the snail has impact on the schistosome
infection. Although 5-methyl-cytosine and 5-hydroxy-methyl-
cytosine were found in the genome of Biomphalaria glabrata
(a snail intermediate host for S. mansoni) and HSP 70 in
the snail was considered as a novel intervention target since
epigenetic modifications at the HSP 70 locus influence B.
glabrata susceptibility to S. mansoni, the knowledge on the snail
epigenetics needs to be further investigated (Fneich et al., 2013;
Knight et al., 2016).
DRUG TARGETS OF EPIGENETIC
REGULATION TO CONTROL
SCHISTOSOMIASIS
Only one drug, praziquantel, is currently available for the
treatment and control of schistosomiasis, and the increasing
risk of schistosomes that are resistant to praziquantel indicates
that the development of new drugs is urgent (Wang et al.,
2012). Numerous histone modifying enzyme (HME) inhibitors
are under investigation as potential anticancer agents. The HMEs
represent particularly promising targets for the development of
alternatives to praziquantel. The crystal structure of inhibited
histone deacetylase 8 (HDAC8) has been elucidated, and
a newly identified smHDAC8 inhibitor has the capacity
to induce apoptosis and mortality in schistosomes (Marek
et al., 2013). These findings define the framework for the
design of small molecule inhibitors that specifically interfere
with schistosome epigenetic mechanisms. Sirtuins are NAD+-
dependent lysine deacetylases that are involved in a wide
variety of cellular processes including histone deacetylation,
and they have been shown to be therapeutic targets in
various pathologies including cancer. All S. mansoni sirtuins
have been expressed throughout the parasitic life cycle and
characterized (Lancelot et al., 2013). Initial experiments in
adult worms and schistosomula have demonstrated strong
effects of hSirt2 inhibitors on both life span and reproduction
(Lancelot et al., 2013), and Schiedel et al. found that the
smSirt2 IC50 was less than 50 µM (Schiedel et al., 2015).
These results suggest that schistosome sirtuins could be potential
therapeutic targets and validate screening for selective sirtuin
inhibitors as a strategy for the development of new drugs against
schistosomiasis.
CONCLUSIONS
In conclusion, epigenetic modifications, including DNA
methylation, histone modifications and non-coding RNAs,
play important roles in the growth, development and
reproduction of schistosomes. DNA methyltransferases,
HDACs or miRNAs can be developed as potential drug
targets or biomarkers against schistosomiasis. Although
great advancements have been achieved in the epigenetic
study of schistosomes, additional details remain unknown.
In future, a large amount of work must be performed in the
epigenetic study of schistosomes. Additionally, epigenetic
processes provide potential therapeutic targets for the
development of novel therapies against schistosomiasis and
other parasitic diseases. These epigenetic modifications are
necessary to ensure the development of parasite-selective
therapies.
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